Medicine Supply Notification: Methylphenidate (Xaggitin® XL) 18mg, 27mg, 36mg and 54mg prolonged-release tablets
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Methylphenidate (Xaggitin® XL) 18mg, 27mg, 36mg and 54mg prolonged-release tablets.
MSN/2022/050
Tier 2 – medium impact
Date of issue 26th May 2022
- Methylphenidate (Xaggitin® XL) 18mg, 27mg and 36mg prolonged-release tablets are out of stock until mid-June 2022.
- Methylphenidate (Xaggitin® XL) 18mg, 27mg and 36mg prolonged-release tablets are out of stock until mid-June 2022
- Alternative brands of methylphenidate prolonged-release tablets including Concerta® XL, Delmosart® and Xenidate® XL remain available and can support an uplift in demand.
- Matoride® XL prolonged-release tablets remain available but are unable to support an uplift in demand.
A copy of this medicine supply notification, including further information, has been sent to all pharmacy NHS email addresses.
DHSC and NHSE/I have now launched an online Medicines Supply Tool, which provides up to date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool.
The Tool also details any changes to resupply dates and updates to the entries.
To access the Tool you will need an NHS email address. Once set up and logged in, you will be able to access it online.
New shortages not listed on the SPS website, can be reported using our shortage reporting tool.
